Cargando…

Erratum to checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?

Detalles Bibliográficos
Autores principales:	Balzarotti, Monica, Santoro, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723609/ https://www.ncbi.nlm.nih.gov/pubmed/33313219 http://dx.doi.org/10.21037/atm-2020-40

Ejemplares similares

Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?
por: Balzarotti, Monica, et al.
Publicado: (2020)

Erratum: Welcome - First Step Forward
Publicado: (2022)

Erratum for Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
Publicado: (2020)

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma
por: Tarekegn, Kidist, et al.
Publicado: (2021)

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
por: Armand, Philippe, et al.
Publicado: (2019)

Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
por: Foss, Francine, et al.
Publicado: (2017)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis: Erratum
Publicado: (2016)

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma
por: Tomassetti, Sarah, et al.
Publicado: (2019)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
por: Madan, V, et al.
Publicado: (2016)

Checkpoint Inhibitors and the Changing Face of the Relapsed/Refractory Classical Hodgkin Lymphoma Pathway
por: Zhang, Xiao-Yin, et al.
Publicado: (2022)

Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients
por: Lucchini, Elisa, et al.
Publicado: (2021)

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170
por: Zinzani, Pier Luigi, et al.
Publicado: (2023)

Erratum: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in diagnosis of mediastinal lesions
Publicado: (2018)

Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

Erratum to combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
Publicado: (2022)

Hepatic angiosarcomatous transformation of a mediastinal germinal cell tumor: A care case report: Erratum
Publicado: (2019)

Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment: Erratum
Publicado: (2020)

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2010)

Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma: Erratum
Publicado: (2014)

Erratum to: Simple steps to develop trial follow-up procedures
por: McCarthy, Ona, et al.
Publicado: (2016)

Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
por: Addeo, Raffaele, et al.
Publicado: (2010)

Erratum to: Objective Biomarkers for Clinical Relapse in Multiple Sclerosis: A Metabolomics Approach
Publicado: (2021)

Abuse-related trauma forward medical care in a randomly sampled nationwide population: Erratum
Publicado: (2017)

Use of Univent tube for intermittent lung isolation during thoracoscopic mediastinal tracheal resection and reconstruction: A case report: Erratum
Publicado: (2018)

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
por: Tzogani, Kyriaki, et al.
Publicado: (2018)

Apatinib in refractory radiation-induced brain Edema: A case report: Erratum
Publicado: (2017)

Apatinib in refractory radiation-induced brain Edema: A case report: Erratum
Publicado: (2018)

Erratum to: Incorporation of causative quantitative trait nucleotides in single-step GBLUP
por: Fragomeni, Breno O., et al.
Publicado: (2017)

Erratum to: One-step multicomponent synthesis of chiral oxazolinyl-zinc complexes
por: Luo, Mei, et al.
Publicado: (2017)

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
por: Aoki, T, et al.
Publicado: (2015)

PB2309: OUTCOMES OF 22 PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: SINGLE INSTITUTE EXPERIENCE
por: Tumyan, Gayane, et al.
Publicado: (2023)

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors: Erratum
Publicado: (2022)

Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015)

Erratum: Breast implant-associated anaplastic large cell lymphoma
Publicado: (2019)

Erratum to: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
por: Romeo, Margarita, et al.
Publicado: (2016)

Erratum to: HARMONY Study: Pimavanserin Significantly Prolongs Time to Relapse of Dementia-Related Psychosis
por: Tariot, Pierre, et al.
Publicado: (2021)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
por: Cho, Hee Jeong, et al.
Publicado: (2023)

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma
por: Okuma, Yusuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dmgprl4e1n7kh2bbtuqg65jo58